Philipp Brauer

Vice President

2024 - Current

Associate

2022 - 2024

Board Observer

2022

Analyst

2021 - 2022

Analyst at EQT Life Sciences (formerly LSP), part of the investment team focused on private companies and involved in all stages of the investment process, especially deal flow screening and scientific due diligence.

Analyst

2020 - 2021

Fellow at M Ventures, the strategic corporate VC of Merck. Supporting the team in all aspects of the fund pipeline including scouting, deal flow, due diligence, portfolio company support and exits.

Year in Research

2013 - 2014

Research in structural biology group, conducting research on intraflagellar trans- port proteins. Performed a full crystallographic research project from inception to publication, working together with a variety of team members to accomplish this in only nine months.

Intern

2012 - 2012

Summer internship focused on BBSome proteins in intraflagellar transport. Performed molecular cloning, expression and purification. Worked as an independent member of a small team.

Intern

2009 - 2009

Two week internship in a small biotech company focused on small molecule drug development and target discovery, involving mass spectrometry, mammalian tissue culture and analysis of mouse organ protein composition.